Roche confirms that its cobas MPXV test, as well as the LightMix® research use only kits, detect the latest mpox virus variants Basel, 20 August 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ...
Roche and its subsidiary TIB Molbiol have developed three different LightMix® Modular Virus kits for the detection of the monkeypox virus Multiple clusters of monkeypox virus have been reported in non ...
Roche announced that the Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use in patients with signs and symptoms of ...
The Swiss pharmaceutical firm Roche has received an emergency authorization from the US Food and Drug Administration (US FDA) for LightMix Ebola Zaire test for emergency use on patients with signs and ...
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday its LightMix Modular Zika Virus Assay (CE) is available in markets accepting the CE mark for patients with signs and symptoms of the Zika ...
Roche and its subsidiary TIB Molbiol have developed three unique LightMix Modular Virus kits in response to recent monkeypox virus concerns. Multiple clusters of the monkeypox virus have been reported ...
Roche said today it has received the FDA’s Emergency Use Authorization (EUA) for its LightMix ® Zika rRT-PCR Test, enabling the company to bypass the agency’s regular approval process. LightMix is an ...
PLEASANTON, California, June 20, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB MOLBIOL, GmbH, announced today the availability of the LightMix Modular Zika Virus Assay (CE) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results